Jove
Visualize
Contact Us

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

699
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
699
Pneumonia IV: Management01:28

Pneumonia IV: Management

664
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
664
Asepsis01:28

Asepsis

2.7K
The condition of being free from disease-causing living pathogens is asepsis. Aseptic techniques include a set of standard practices to achieve asepsis. An example is the regular environmental cleaning of all parts of the healthcare facility and hand hygiene at home before preparing or eating food. Medical and surgical asepsis in healthcare practice protects patients from harmful pathogens, minimizes the risk of contamination of susceptible sites, and reduces the risk of infection transmission.
2.7K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

187
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
187
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

906
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
906
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

656
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
656

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary Paragonimiasis Presenting as Pneumothorax, Hemoptysis, and Severe Eosinophilia: A Case Report.

Case reports in infectious diseases·2026
Same author

Isolated Palmar Hyperpigmentation: Rare Presentation of B12 Deficiency.

Clinical case reports·2026
Same author

Diagnostic utility of 16S rRNA meta genomic next-generation sequencing in clinical infectious diseases practice: a retrospective study from South India.

Indian journal of medical microbiology·2026
Same author

Extracting adverse event nature, severity, timelines and resulting interventions from clinical notes of patients receiving CAR-T therapy using large language models.

medRxiv : the preprint server for health sciences·2026
Same author

Milky Blood in a Middle-Aged Man With Diabetes Mellitus: Familial Chylomicronemia Syndrome due to GPIHBP1 Mutation.

Clinical case reports·2026
Same author

Serotype specific differences among inpatient and outpatient dengue fever patients at a tertiary care hospital in Western Maharashtra.

Medical journal, Armed Forces India·2026
Same journal

Methodological considerations in estimating the burden of congenital heart disease among Indian children.

Indian journal of thoracic and cardiovascular surgery·2026
Same journal

Cardiac transplantation in situs inversus post-TAPVC repair.

Indian journal of thoracic and cardiovascular surgery·2026
Same journal

Size compatibility in pediatric heart transplantation: impact on outcomes.

Indian journal of thoracic and cardiovascular surgery·2026
Same journal

Pulmonary NUT carcinoma mimicking small cell lung cancer: a diagnostic pitfall in high-grade thoracic tumors.

Indian journal of thoracic and cardiovascular surgery·2026
Same journal

Burden of congenital heart disease among Indian children: a systematic review and meta analysis.

Indian journal of thoracic and cardiovascular surgery·2026
Same journal

Outcomes of coronary artery bypass grafting: insights from a single centre in South India.

Indian journal of thoracic and cardiovascular surgery·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 21, 2025

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.4K

Sepsis and ECMO.

Ram Gopalakrishnan1, Rohit Vashisht1

  • 1Department of Infectious Diseases, Apollo Hospital, Chennai, 600 006 India.

Indian Journal of Thoracic and Cardiovascular Surgery
|May 19, 2020
PubMed
Summary
This summary is machine-generated.

Sepsis is a serious complication of extracorporeal membrane oxygenation (ECMO), increasing mortality. Early detection, appropriate antimicrobial therapy, and strict infection control are crucial for improving outcomes in high-risk ECMO patients.

Keywords:
AntimicrobialsCultureECMOInfection controlSepsis

More Related Videos

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.8K
Cecal Ligation Puncture Procedure
11:53

Cecal Ligation Puncture Procedure

Published on: May 7, 2011

56.0K

Related Experiment Videos

Last Updated: Dec 21, 2025

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.4K
Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.8K
Cecal Ligation Puncture Procedure
11:53

Cecal Ligation Puncture Procedure

Published on: May 7, 2011

56.0K

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Cardiovascular Surgery

Background:

  • Sepsis is a significant complication of extracorporeal membrane oxygenation (ECMO), associated with poor prognosis and increased mortality.
  • Adult patients requiring prolonged ECMO support are at the highest risk.
  • Common sources of sepsis in ECMO patients include ventilator-associated pneumonia and bloodstream infections.

Purpose of the Study:

  • To highlight the importance of recognizing sepsis as a complication in ECMO patients.
  • To discuss the prognostic implications and risk factors associated with sepsis in ECMO.
  • To emphasize strategies for prevention and management of sepsis in this population.

Main Methods:

  • Review of existing literature on sepsis in ECMO patients.
  • Analysis of risk factors, etiological agents, and outcomes.
  • Discussion of diagnostic and therapeutic considerations, including antimicrobial dosing and infection control.

Main Results:

  • Sepsis presence is a poor prognostic marker in ECMO.
  • Prolonged ECMO duration in adults is a major risk factor.
  • Etiological agents of sepsis vary based on hospital epidemiology.

Conclusions:

  • Early recognition, adequate blood cultures, and prompt empirical antimicrobial administration are vital.
  • Antimicrobial dosing must account for ECMO-related pharmacokinetic changes.
  • Meticulous infection control practices are essential for sepsis prevention in ECMO.